Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home

References

• Interim U.S. Guidance for risk assessment and public health management of healthcare personnel with potential exposure in a healthcare setting to patients with coronavirus disease (COVID-19). Center for Disease Control and Prevention; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html. Accessed September 14, 2021.
   Google Scholar
• Johnston SL. Overview of virus-induced airway disease. Proc Am Thorac Soc. 2005;2(2):150–156. doi:10.1513/pats.200502-018AW
   PubMedGoogle Scholar
• Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23(2):130–137. doi:10.1111/resp.13196
   PubMed Web of Science ®Google Scholar
• Kerkhove V, Alaswad S, Assiri A, et al. Transmissibility of MERS-CoV infection in closed setting. Emerg Infect Dis. 2015;25:1802–1809.
   Google Scholar
• Assaf SM, Tarasevych SP, Diamant Z, Hanania NA. Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021;27(1):45–53. doi:10.1097/MCP.0000000000000744
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438. doi:10.1016/S2213-2600(20)30167-3
   PubMed Web of Science ®Google Scholar
• Recommendations for inhaled asthma controller medications. Global Initiative for Asthma; 2020. Available from: https://ginasthma.org/recommendations-for-inhaled-asthma-controller-medications/. Accessed September 14, 2021.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2020 report; 2020. Available from: http://www.goldcopd.org. Accessed September 14, 2021.
   Google Scholar
• Ari A. Use of aerosolised medications at home for COVID-19. Lancet Respir Med. 2020;8(8):754–756. doi:10.1016/S2213-2600(20)30270-8
   PubMedGoogle Scholar
• Ari A, Restrepo RD. Aerosol delivery device selection for spontaneously breathing patients: 2012. Respir Care. 2012;57(4):613–626. doi:10.4187/respcare.01756
   PubMed Web of Science ®Google Scholar
• Ari A, Fink J. Guidelines to aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy? Expert Rev Respir Med. 2011;5(4):561–572. doi:10.1586/ers.11.49
   PubMed Web of Science ®Google Scholar
• Ari A, Fink JB. Differential medical aerosol device and interface selection in patients during spontaneous, conventional mechanical and noninvasive ventilation. J Aerosol Med Pulm Drug Deliv. 2016;29(2):95–106. doi:10.1089/jamp.2015.1266
   PubMed Web of Science ®Google Scholar
• DePietro M, Gilbert I, Millette LA, Riebe M. Inhalation device options for the management of chronic obstructive pulmonary disease. Postgrad Med. 2018;130(1):83–97. doi:10.1080/00325481.2018.1399042
   PubMed Web of Science ®Google Scholar
• Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75(1):18–25. doi:10.1159/000109374
   PubMed Web of Science ®Google Scholar
• Jarvis S, Ind PW, Shiner RJ. Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing. 2007;36(2):213–218. doi:10.1093/ageing/afl174
   PubMed Web of Science ®Google Scholar
• Fromer L, Goodwin E, Walsh J. Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med. 2010;122(2):83–93. doi:10.3810/pgm.2010.03.2125
   PubMed Web of Science ®Google Scholar
• Lavorini F, Mannini C, Chellini E, Fontana GA. Optimising inhaled pharmacotherapy for elderly patients with chronic obstructive pulmonary disease: the importance of delivery devices. Drugs Aging. 2016;33(7):461–473. doi:10.1007/s40266-016-0377-y
   PubMed Web of Science ®Google Scholar
• Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360–1374.
   PubMedGoogle Scholar
• Fink JB. Inhalers in asthma management: is demonstration the key to compliance? Respir Care. 2005;50:598–600.
   PubMedGoogle Scholar
• Lewis RM, Fink JB. Promoting adherence to inhaled therapy: building partnerships through patient education. Respir Care Clin N Am. 2001;7(2):277–301,vi. doi:10.1016/S1078-5337(05)70034-4
   PubMedGoogle Scholar
• Hanania NA, Braman S, Adams SG, et al. The role of inhalation delivery devices in COPD: perspectives of patients and health care providers. Chronic Obstr Pulm Dis. 2018;5(2):111–123. doi:10.15326/jcopdf.5.2.2017.0168
   PubMed Web of Science ®Google Scholar
• Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med. 2020;167:105987. doi:10.1016/j.rmed.2020.105987
   PubMed Web of Science ®Google Scholar
• Ari A. Promoting safe and effective use of aerosol devices in COVID-19: risks and suggestions for viral transmission. Expert Opin Drug Deliv. 2020;17(11):1509–1513. doi:10.1080/17425247.2020.1811225
   PubMed Web of Science ®Google Scholar
• Ari A. Patient education and adherence to aerosol therapy. Respir Care. 2015;60(6):941–955. doi:10.4187/respcare.03854
   PubMed Web of Science ®Google Scholar
• Ari A, Fink J. Aerosol therapy in children: challenges and solutions. Expert Rev Respir Med. 2013;7(6):665–672. doi:10.1586/17476348.2013.847369
   PubMed Web of Science ®Google Scholar
• Dhand R, Mahler DA, Carlin BW, et al. Results of a patient survey regarding COPD knowledge, treatment experiences, and practices with inhalation devices. Respir Care. 2018;63(7):833–839. doi:10.4187/respcare.05715
   PubMed Web of Science ®Google Scholar
• Luczak-Wozniak K, Dabrowska M, Domagala I, et al. Mishandling of pMDI and DPI inhalers in asthma and COPD – repetitive and non-repetitive errors. Pulm Pharmacol Ther. 2018;51:65–72. doi:10.1016/j.pupt.2018.06.002
   PubMed Web of Science ®Google Scholar
• Riley J, Krüger P. Optimising inhaler technique in chronic obstructive pulmonary disease: a complex issue. Br J Nurs. 2017;26(7):391–397. doi:10.12968/bjon.2017.26.7.391
   PubMedGoogle Scholar
• Elbeddini A, Yeats A. Amid COVID-19 drug shortages: proposed plan for reprocessing and reusing salbutamol pressurized metered dose inhalers (pMDIs) for shared use. Drugs Ther Perspect. 2020;36:1–3.
   Google Scholar
• Press VG, Gershon AS, Sciurba FC, Blagev DP. Concerns about coronavirus disease-related collateral damage for patients with COPD. Chest. 2020;158(3):866–868. doi:10.1016/j.chest.2020.05.549
   PubMed Web of Science ®Google Scholar
• Ari A. Jet, mesh and ultrasonic nebulizers: an evaluation of nebulizers for better clinical practice. Eurasian J Pulmonol. 2014;16:1–7.
   Google Scholar
• Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47:1257–1275.
   PubMedGoogle Scholar
• Ari A. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models. Pediatr Pulmonol. 2019;54(11):1735–1741. doi:10.1002/ppul.24449
   PubMed Web of Science ®Google Scholar
• Ari A, de Andrade AD, Sheard M, AlHamad B, Fink JB. Performance comparisons of jet and mesh nebulizers using different interfaces in simulated spontaneously breathing adults and children. J Aerosol Med Pulm Drug Deliv. 2015;28(4):281–289. doi:10.1089/jamp.2014.1149
   PubMed Web of Science ®Google Scholar
• O’Toole C, McGrath J, Bennett G, Joyce M, MacLoughlin R, Byrne M. Fugitive emissions from a breath actuated jet nebuliser and a vibrating mesh nebuliser for a paediatric patient. In: ISES-ISIAQ 2019; 2019; Kaunas, Lithuania.
   Google Scholar
• Mitchell JP, Nagel MW. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Respir J. 2007;16(4):207–214. doi:10.3132/pcrj.2007.00034
   PubMedGoogle Scholar
• Wildhaber JH, Devadason SG, Eber E, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax. 1996;51(10):985–988. doi:10.1136/thx.51.10.985
   PubMed Web of Science ®Google Scholar
• Wildhaber JH, Janssens HM, Pierart F, Dore ND, Devadason SG, LeSouef PN. High-percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol. 2000;29(5):389–393. doi:10.1002/(SICI)1099-0496(200005)29:5<389::AID-PPUL8>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Wildhaber J, Devadason S, Hayden M, et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J. 1996;9(9):1943–1946. doi:10.1183/09031936.96.09091943
   PubMed Web of Science ®Google Scholar
• Pierart F, Wildhaber J, Vrancken I, Devadason SG, Le Souef PN. Washing spacers in household detergent reduces electrostatic charge and greatly improves delivery. Eur Respir J. 1999;13(3):673–678. doi:10.1183/09031936.99.13367399
   PubMed Web of Science ®Google Scholar
• Dompeling E, Oudesluys-Murphy AM, Janssens HM, et al. Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge. Arch Dis Child. 2001;84(2):178–182. doi:10.1136/adc.84.2.178
   PubMed Web of Science ®Google Scholar
• Anhoj J, Bisgaard H, Lipworth BJ. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children. Br J Clin Pharmacol. 1999;47(3):333–336. doi:10.1046/j.1365-2125.1999.00893.x
   PubMed Web of Science ®Google Scholar
• Bisgaard H, Anhoj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Child. 1995;73(3):226–230. doi:10.1136/adc.73.3.226
   PubMed Web of Science ®Google Scholar
• Ari A. Drug delivery interfaces: a way to optimize inhalation therapy in spontaneously breathing children. World J Clin Pediatr. 2016;5(3):281–287. doi:10.5409/wjcp.v5.i3.281
   PubMedGoogle Scholar
• McGrath J, O’Toole C, Joyce GB, Joyce M, Byrne MA, MacLoughlin R. Investigation of fugitive aerosols released into the environment during high-flow therapy. Pharmaceutics. 2019;11(6):254. doi:10.3390/pharmaceutics11060254
   PubMed Web of Science ®Google Scholar
• Ari A. Optimizing inhalation therapy in spontaneously breathing patients. Clin Pulm Med. 2014;21(1):34–41. doi:10.1097/CPM.0000000000000019
   Google Scholar
• Rubin BK. Air and soul: the science and application of aerosol therapy. Respir Care. 2010;55:911–921.
   PubMed Web of Science ®Google Scholar
• Rau JL. 2004 Philip Kittredge Memorial Lecture. The inhalation of drugs: advantages and problems. Respir Care. 2005;50:367–382.
   PubMedGoogle Scholar
• Rau JL. Practical problems with aerosol therapy in COPD. Respir Care. 2006;51:158–172.
   PubMed Web of Science ®Google Scholar
• McFadden ER Jr. Improper patient techniques with metered dose inhalers: clinical consequences and solutions to misuse. J Allergy Clin Immunol. 1995;96(2):278–283. doi:10.1016/S0091-6749(95)70206-7
   PubMed Web of Science ®Google Scholar
• Lavorini F, Levy ML, Corrigan C, Crompton G. The ADMIT series - issues in inhalation therapy. 6) training tools for inhalation devices. Prim Care Respir J. 2010;19(4):335–341. doi:10.4104/pcrj.2010.00065
   PubMedGoogle Scholar
• Chrystyn H. Is inhalation rate important for a dry powder inhaler? Using the in-check dial to identify these rates. Respir Med. 2003;97(2):181–187. doi:10.1053/rmed.2003.1351
   PubMed Web of Science ®Google Scholar
• Fiato KL, Iwamoto GK, Harkins MS, Morelos J. Monitoring flow rates and retention of inhalation techniques using the in-check dial device in adult asthmatics. J Asthma. 2007;44(3):209–212. doi:10.1080/02770900701209798
   PubMed Web of Science ®Google Scholar
• Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol. 2005;39(5):447–451. doi:10.1002/ppul.20180
   PubMed Web of Science ®Google Scholar
• van der Palen J. Peak inspiratory flow through diskus and turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). Respir Med. 2003;97(3):285–289. doi:10.1053/rmed.2003.1289
   PubMed Web of Science ®Google Scholar
• Saeed H, Mohsen M, Fink J, et al. Fill volume, humidification and heat effects on aerosol delivery and fugitive emissions during noninvasive ventilation. J Drug Deliv Sci Technol. 2017;39:372–378. doi:10.1016/j.jddst.2017.04.026
   Web of Science ®Google Scholar
• Nazaroff W. Indoor bioaerosol dynamics. Indoor Air. 2016;26(1):61–78. doi:10.1111/ina.12174
   PubMed Web of Science ®Google Scholar
• Long C, Suh H, Catalano P, Koutrakis P. Using time- and size-resolved particulate data to quantify indoor penetration and deposition behavior. Environ Sci Technol. 2001;35(10):2089–2099. doi:10.1021/es001477d
   PubMed Web of Science ®Google Scholar
• McGrath J, Byrne M, Ashmore M, Terry A, Dimitroulopoulou C. Development of a probabilistic multi-zone multi-source computational model and demonstration of its applications in predicting PM concentrations indoors. Sci Total Environ. 2014;490:798–806. doi:10.1016/j.scitotenv.2014.05.081
   PubMed Web of Science ®Google Scholar
• McGrath J, Byrne M, Ashmore M, Terry A, Dimitroulopoulou C. A simulation study of the changes in PM2.5 concentrations due to interzonal airflow variations caused by internal door opening patterns. Atmos Environ. 2014;87:183–188. doi:10.1016/j.atmosenv.2014.01.050
   Web of Science ®Google Scholar
• Ciuzas D, Prasauskas T, Krugly E, et al. Characterization of indoor aerosol temporal variations for the real-time management of indoor air quality. Atmos Environ. 2015;118:107–117. doi:10.1016/j.atmosenv.2015.07.044
   Web of Science ®Google Scholar
• Tran K, Cimon K, Severn M, Pessoa-Silva C, Conly J, Semple MG. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7(4):e35797. doi:10.1371/journal.pone.0035797
   PubMed Web of Science ®Google Scholar
• Wittgen BP, Kunst PW, Perkins WR, Lee JK, Postmus PE. Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin. J Aerosol Sci. 2006;19(3):385–391. doi:10.1089/jam.2006.19.385
   Web of Science ®Google Scholar
• Ari A, Scott JB. Lessons learned about aerosol drug delivery in the era of COVID-19. CHEST; 2021. Available from: https://www.chestnet.org/Topic-Collections/COVID-19/COVID-in-Focus/Lessons-Learned-About-Aerosol-Drug-Delivery-in-the-Era-of-COVID-19. Accessed September 14, 2021.
   Google Scholar
• O’Malley CA. Device cleaning and infection control in aerosol therapy. Respir Care. 2015;60(6):917–927. doi:10.4187/respcare.03513
   PubMed Web of Science ®Google Scholar
• Tablan O, Anderson L, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health care–associated pneumonia. Recommendations of the CDC and the healthcare infection control practices advisory committee. MMWR Recommendations & Reports; 2004 [updated March 26, 2004; cited January 19, 2009]. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5303a1.htm. Accessed September 14, 2021.
   Google Scholar
• Cleaning and disinfecting nebulizers. Cystic FIbrosis Foundation; 2019. Available from: https://www.cff.org/Life-With-CF/Treatments-and-Therapies/Medications/Nebulizer-Care-at-Home/. Accessed September 14, 2021.
   Google Scholar
• Kriegel M, Buchholz P, Gastmeier P, Bischoff P, Abdelgawad I, Hartmann A. Predicted infection risk for aerosol transmission of SARS-CoV-2. Medrxiv. 2020. Available from: https://www.medrxiv.org/content/10.1101/2020.10.08.20209106v5. Accessed September 14, 2021.
   Google Scholar
• Kupper M, Asbach C, Schneiderwind U, Finger H, Spiegelhoff D, Schumacher S. Testing of an indoor air cleaner for particulate pollutants under realistic conditions in an office room. Aerosol Air Qual Res. 2019;19(8):1655–1665. doi:10.4209/aaqr.2019.01.0029
   Web of Science ®Google Scholar
• Pei J, Dong C, Liu J. Operating behavior and corresponding performance of portable air cleaners in residential buildings, China. Build Environ. 2019;147:473–481. doi:10.1016/j.buildenv.2018.08.009
   Web of Science ®Google Scholar
• Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. World Health Organization; 2020 [updated May 14, 2020]. Available from: https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts. Accessed September 14, 2021.
   Google Scholar
• Fink J, Ehrmann S, Li J, et al. Reducing aerosol-related risk of transmission in the era of COVID-19. J Aerosol Med Pulm Drug Deliv. 2020;33(6):300–304. doi:10.1089/jamp.2020.1615
   PubMed Web of Science ®Google Scholar
• Jensen MH, Cichosz SL, Hejlesen OK, et al. Clinical impact of home telemonitoring on patients with chronic obstructive pulmonary disease. Telemed J E Health. 2012;18(9):674–678. doi:10.1089/tmj.2012.0003
   PubMed Web of Science ®Google Scholar
• Sanchez-Morillo D, Fernandez-Granero MA, Jiménez AL. Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a Pilot Study. Med Biol Eng Comput. 2015;53(5):441–451. doi:10.1007/s11517-015-1252-4
   PubMed Web of Science ®Google Scholar
• Alrajab S, Smith TR, Owens M, Areno JP, Caldito G. A home telemonitoring program reduced exacerbation and healthcare utilization rates in COPD patients with frequent exacerbations. Telemed J E Health. 2012;18(10):772–776. doi:10.1089/tmj.2012.0005
   PubMed Web of Science ®Google Scholar
• Antoniades Nc, Rochford PD, Pretto JJ, et al. Pilot study of remote telemonitoring in COPD. Telemed J E Health. 2012;18(8):634–640. doi:10.1089/tmj.2011.0231
   PubMed Web of Science ®Google Scholar
• Fairbrother P, Pinnock H, Hanley J, et al. Exploring telemonitoring and self-management by patients with chronic obstructive pulmonary disease: a qualitative study embedded in a randomized controlled trial. Patient Educ Couns. 2013;93(3):403–410. doi:10.1016/j.pec.2013.04.003
   PubMed Web of Science ®Google Scholar
• Ho TW, Huang CT, Chiu HC, et al. Effectiveness of telemonitoring in patients with chronic obstructive pulmonary disease in Taiwan-a randomized controlled trial. Sci Rep. 2016;6(1):23797. doi:10.1038/srep23797
   PubMedGoogle Scholar
• Kim J, Kim S, Kim H, et al. Acceptability of the consumer-centric u-health services for patients with chronic obstructive pulmonary disease. Telemed J E Health. 2012;18(5):329–338. doi:10.1089/tmj.2011.0140
   PubMed Web of Science ®Google Scholar
• McDowell JE, McClean S, FitzGibbon F, Tate S. A randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPD. J Telemed Telecare. 2015;21(2):80–87. doi:10.1177/1357633X14566575
   PubMed Web of Science ®Google Scholar
• Pedone C, Lelli D. Systematic review of telemonitoring in COPD: an update. Pneumonol Alergol Pol. 2015;83(6):476–484. doi:10.5603/PiAP.2015.0077
   PubMedGoogle Scholar
• Reddel HK, Jenkins CR, Partridge MR. Self-management support and other alternatives to reduce the burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2014;18(12):1396–1406. doi:10.5588/ijtld.14.0371
   PubMed Web of Science ®Google Scholar
• Venter A, Burns R, Hefford M, Ehrenberg N. Results of a telehealth-enabled chronic care management service to support people with long-term conditions at home. J Telemed Telecare. 2012;18(3):172–175. doi:10.1258/jtt.2012.SFT112
   PubMed Web of Science ®Google Scholar
• Burton C, Pinnock H, McKinstry B. Changes in telemonitored physiological variables and symptoms prior to exacerbations of chronic obstructive pulmonary disease. J Telemed Telecare. 2015;21(1):29–36. doi:10.1177/1357633X14562733
   PubMed Web of Science ®Google Scholar
• Chatwin M, Hawkins G, Panicchia L, et al. Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial). Thorax. 2016;71(4):305–311. doi:10.1136/thoraxjnl-2015-207045
   PubMed Web of Science ®Google Scholar
• Vianello A, Fusello M, Gubian L, et al. Home telemonitoring for patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2016;16(1):157. doi:10.1186/s12890-016-0321-2
   PubMedGoogle Scholar
• Elwyn G, Hardisty AR, Peirce SC, et al. Detecting deterioration in patients with chronic disease using telemonitoring: navigating the ‘trough of disillusionment’. J Eval Clin Pract. 2012;18(4):896–903. doi:10.1111/j.1365-2753.2011.01701.x
   PubMed Web of Science ®Google Scholar
• Martín-Lesende I, Orruño E, Bilbao A, et al. Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial). BMC Health Serv Res. 2013;13(1):118. doi:10.1186/1472-6963-13-118
   PubMedGoogle Scholar
• Davis C, Bender M, Smith T, Broad J. Feasibility and acute care utilization outcomes of a post-acute transitional telemonitoring program for underserved chronic disease patients. Telemed J E Health. 2015;21(9):705–713. doi:10.1089/tmj.2014.0181
   PubMed Web of Science ®Google Scholar
• Fairbrother P, Pinnock H, Hanley J, et al. Continuity, but at what cost? The impact of telemonitoring COPD on continuities of care: a qualitative study. Prim Care Respir J. 2012;21(3):322–328. doi:10.4104/pcrj.2012.00068
   PubMedGoogle Scholar
• Stoddart A, van der Pol M, Pinnock H, et al. Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial. J Telemed Telecare. 2015;21(2):108–118. doi:10.1177/1357633X14566574
   PubMed Web of Science ®Google Scholar